Endoscopic ultrasound (EUS) and the management of pancreatic cancer.
Muhammad Nadeem YousafFizah S ChaudharyAmrat EhsanAlejandro L SuarezThiruvengadam MunirajPriya JamidarHarry R AslanianJames J FarrellPublished in: BMJ open gastroenterology (2021)
Pancreatic cancer is one of the leading causes of cancer-related mortality in western countries. Early diagnosis of pancreatic cancers plays a key role in the management by identification of patients who are surgical candidates. The advancement in the radiological imaging and interventional endoscopy (including endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography and endoscopic enteral stenting techniques) has a significant impact in the diagnostic evaluation, staging and treatment of pancreatic cancer. The multidisciplinary involvement of radiology, gastroenterology, medical oncology and surgical oncology is central to the management of patients with pancreatic cancers. This review aims to highlight the diagnostic and therapeutic role of EUS in the management of patients with pancreatic malignancy, especially pancreatic ductal adenocarcinoma.
Keyphrases
- ultrasound guided
- fine needle aspiration
- magnetic resonance imaging
- end stage renal disease
- healthcare
- palliative care
- chronic kidney disease
- ejection fraction
- lymph node
- type diabetes
- risk factors
- cardiovascular disease
- machine learning
- prognostic factors
- cardiovascular events
- endoscopic submucosal dissection
- antiplatelet therapy
- patient reported outcomes
- childhood cancer